Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hematological Inflammatory Markers in Patients With Clinically Confirmed Familial Hypercholesterolemia Publisher Pubmed



Vaseghi G1 ; Heshmatghahdarijani K2 ; Taheri M3 ; Ghasempoor G2 ; Hajian S3 ; Haghjooyjavanmard S1 ; Aliyari R4 ; Shafiee Z5 ; Shekarchizadeh M3 ; Pourmoghadas A2 ; Sarrafzadegan N3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Biostatistics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  5. 5. Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: BioMed Research International Published:2022


Abstract

Background and Aims. Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder of lipid metabolism which leads to premature cardiovascular diseases. In patients with FH, blood inflammatory markers may be disrupted; however, its extent is unclear. In this study, we aimed to evaluate the NLR (neutrophil to lymphocyte ratio), PLR (platelet count to lymphocyte count ratio), MPV (mean platelet volume), RPR (red blood cell distribution width to platelet count ratio), WBC (white blood cell), and PDW (platelet distribution width and platelet count). Methods. The patients were selected from laboratories due to high cholesterol level and who had history of premature cardiovascular disease. The Dutch Lipid Clinic Network (DLCN) criteria are used for the detection of FH. Controls had a history of hyperlipidemia, and both groups could be on pharmacotherapy or not. All the biochemical markers were evaluated using appreciate methods. Statistical analysis was done using STATA 14. Results. The study group consisted of 1074 patients with FH and 473 control cases. Of the CBC inflammatory markers, only PLR was significantly (p value=0.003) higher in FH patients (7.96±10.08) compared to non-FH (6.45±2.44). In FH patients, the PLR was significantly higher in probable/definite FH group (9.70±14.06) compared to possible FH (7.36±8.23) (p value<0.001). Linear regression analysis showed that only RLR was independently associated with total cholesterol (b=0.000, p=0.13). Conclusions. Our results may show the importance of high cholesterol on platelet activity and highlight the use of lipid lowering drugs in patients with hyperlipidemia. © 2022 Golnaz Vaseghi et al.
Other Related Docs
9. Cord Blood Lipoprotein Profile in Term, Preterm, and Late Preterm Newborns, Journal of Research in Medical Sciences (2014)
13. Prevalence of Total Cholesterol in Iran: Systematic Review and Meta-Analysis, Journal of Mazandaran University of Medical Sciences (2015)
15. First Report on the Lipid Profile Late After Kawasaki Disease in Iranian Children, International Journal of Preventive Medicine (2014)
18. Effect of Cardiac Rehabilitation on Lipid Profile, Journal of Association of Physicians of India (2003)
19. Is Lp(A), As Predictor of Severity of Coronary Artery Disease?, Journal of Isfahan Medical School (2009)
22. Dietary Patterns in Relation to Lipid Profiles Among Iranian Adults, Journal of Cardiovascular and Thoracic Research (2019)
36. Anethum Graveolens and Hyperlipidemia: A Randomized Clinical Trial, Journal of Research in Medical Sciences (2014)
39. Association Between Severity of Coronary Disease and Apolipoproteins a and B, Iranian Journal of Endocrinology and Metabolism (2011)